These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27274291)

  • 1. The economic impact of educational training assessed by the Handling Questionnaire with three inhalation devices in asthma and Chronic Obstructive Pulmonary Disease patients.
    Dal Negro RW; Povero M
    Clinicoecon Outcomes Res; 2016; 8():171-6. PubMed ID: 27274291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dry-powder inhalers in patients with persistent airflow limitation: usability and preference.
    Dal Negro RW; Povero M
    Multidiscip Respir Med; 2016; 11(1):31. PubMed ID: 27597888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability and preference of three inhalation devices assessed by the Handling Questionnaire in asthma and COPD patients.
    Dal Negro RW; Povero M
    Multidiscip Respir Med; 2015; 11():7. PubMed ID: 26865979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferences and Inhalation Techniques for Inhaler Devices Used by Patients with Chronic Obstructive Pulmonary Disease.
    Bournival R; Coutu R; Goettel N; Yang CD; Cantin-Lafleur A; Lemieux C; Lévesque AM; Patenaude-Monette JF; Roy FO; Blais L; Arbour F; Fillion A; Beauchesne MF
    J Aerosol Med Pulm Drug Deliv; 2018 Aug; 31(4):237-247. PubMed ID: 29206566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Satisfaction, preference and error occurrence of three dry powder inhalers as assessed by a cohort naïve to inhaler operation.
    Man KN; Tian Z; Lam DC; Wan JMF; Tan-Un KC
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1949-1963. PubMed ID: 29942127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study.
    Pascual S; Feimer J; De Soyza A; Sauleda Roig J; Haughney J; Padullés L; Seoane B; Rekeda L; Ribera A; Chrystyn H
    NPJ Prim Care Respir Med; 2015 Apr; 25():15018. PubMed ID: 25927321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with appropriate inhaler use in patients with COPD - lessons from the REAL survey.
    Price D; Keininger DL; Viswanad B; Gasser M; Walda S; Gutzwiller FS
    Int J Chron Obstruct Pulmon Dis; 2018; 13():695-702. PubMed ID: 29520137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD.
    Miravitlles M; Montero-Caballero J; Richard F; Santos S; Garcia-Rivero JL; Ortega F; Ribera X
    Int J Chron Obstruct Pulmon Dis; 2016; 11():407-15. PubMed ID: 27013871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COPD Patients' Behaviour When Involved in the Choice of Inhaler Device.
    Bivolaru S; Constantin A; Vlase CM; Gutu C
    Healthcare (Basel); 2023 May; 11(11):. PubMed ID: 37297746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the preference, satisfaction and correct use of Breezhaler
    Oliveira MVC; Pizzichini E; da Costa CH; Fritscher CC; Vianna EO; Teixeira PJZ; Stirbulov R; Rabahi MF; Pinho NC
    Respir Med; 2018 Nov; 144():61-67. PubMed ID: 30366585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirements, Strengths and Weaknesses of Inhaler Devices for COPD Patients from the Expert Prescribers' Point of View: Results of the EPOCA Delphi Consensus.
    García-Río F; Soler-Cataluña JJ; Alcazar B; Viejo JL; Miravitlles M
    COPD; 2017 Dec; 14(6):573-580. PubMed ID: 28891722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing Inhaler Use Technique Based on Inhaler Type in Elderly Patients with Respiratory Disease.
    Lee HY; Song JH; Won HK; Park Y; Chung KB; Lim HJ; Ahn YM; Lee BJ
    Tuberc Respir Dis (Seoul); 2021 Jan; 84(1):46-54. PubMed ID: 32981292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of switching tiotropium HandiHaler® to Respimat® Soft Mist™ Inhaler in patients with COPD: the difference of adverse events and usability between inhaler devices.
    Asakura Y; Nishimura N; Maezawa K; Terajima T; Kizu J; Chohnabayashi N
    J Aerosol Med Pulm Drug Deliv; 2013 Feb; 26(1):41-5. PubMed ID: 22691112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro dose comparison of Respimat
    Ciciliani AM; Langguth P; Wachtel H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1565-1577. PubMed ID: 28603412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease.
    Kässner F; Hodder R; Bateman ED
    Drugs; 2004; 64(15):1671-82. PubMed ID: 15257628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ease-of-use preference for the ELLIPTA® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older.
    Komase Y; Asako A; Kobayashi A; Sharma R
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1365-75. PubMed ID: 25525354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments in inhaler devices within pharmaceutical companies: A systematic review of the impact on clinical outcomes and patient preferences.
    Ninane V; Vandevoorde J; Cataldo D; Derom E; Liistro G; Munghen E; Peché R; Schlesser M; Verleden G; Vincken W
    Respir Med; 2015 Nov; 109(11):1430-8. PubMed ID: 26439177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland.
    Tschacher A; Cadus C; Schildge S; Diedrich JP; Chhajed PN; Leuppi-Taegtmeyer AB; Leuppi JD
    Curr Med Res Opin; 2021 Nov; 37(11):2019-2033. PubMed ID: 34433362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the development of Respimat Soft Mist Inhaler.
    Dalby R; Spallek M; Voshaar T
    Int J Pharm; 2004 Sep; 283(1-2):1-9. PubMed ID: 15363496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhalation therapy with Respimat soft inhaler in patients with COPD and asthma].
    Voshaar T; Hausen T; Kardos P; Köhler D; Schultze-Werninghaus G; Schürmann W; Vogelmeier C
    Pneumologie; 2005 Jan; 59(1):25-32. PubMed ID: 15685486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.